» Authors » Hiroo Umeda

Hiroo Umeda

Explore the profile of Hiroo Umeda including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 108
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kanemaru S, Umeda H, Kanai R, Tsuji T, Kuboshima F, Yamamoto M, et al.
Otol Neurotol . 2014 Feb; 35(3):442-8. PMID: 24518405
Objective: To establish a regenerative treatment for soft tissue defects of the external auditory meatus (EAM) without conventional surgical therapy. Study Design: Controlled clinical pilot study. Setting: General hospitals. Patients:...
2.
Kanemaru S, Umeda H, Yamashita M, Hiraumi H, Hirano S, Nakamura T, et al.
Laryngoscope . 2012 Oct; 123(2):472-6. PMID: 23086494
Objectives/hypothesis: Most cases of chronic otitis media (OMC) are associated with poor development of the mastoid air cells (MACs) and poor Eustachian tube (ET) function. We have previously reported that...
3.
Kanemaru S, Umeda H, Kitani Y, Nakamura T, Hirano S, Ito J
Otol Neurotol . 2011 Sep; 32(8):1218-23. PMID: 21897328
Objective: To establish a tissue engineering therapy for the treatment of large tympanic membrane perforation (TMP) without the need for conventional surgical therapy. Study Design: Randomized control trial. Setting: General...
4.
Kitani Y, Kanemaru S, Umeda H, Suehiro A, Kishimoto Y, Hirano S, et al.
Ann Otol Rhinol Laryngol . 2011 Mar; 120(1):49-56. PMID: 21370680
Objectives: We previously reported that polypropylene mesh covered with collagen sponge is a useful material for the regeneration of the trachea and the cricoid cartilage. The aim of this study...
5.
Kanemaru S, Hirano S, Umeda H, Yamashita M, Suehiro A, Nakamura T, et al.
Acta Otolaryngol Suppl . 2010 Oct; (563):79-83. PMID: 20879824
Conclusion: This new regenerative therapy shows great potential for the treatment of stenosis of the trachea and/or cricoids (STC). Objectives: To estimate the potential of tissue-engineered artificial trachea (AT) for...
6.
Yamashita M, Kanemaru S, Hirano S, Umeda H, Kitani Y, Omori K, et al.
Ann Otol Rhinol Laryngol . 2010 Mar; 119(2):110-7. PMID: 20336922
Objectives: The larynx must be resected in some cases of cancer or stenosis, and various techniques are generally employed to fill the resulting defect. No ideal way, however, has been...
7.
Ohno S, Hirano S, Tateya I, Kanemaru S, Umeda H, Suehiro A, et al.
Ann Otol Rhinol Laryngol . 2009 Dec; 118(11):805-10. PMID: 19999367
Objectives: Treatment of vocal fold scarring remains a therapeutic challenge. Our group previously reported the efficacy of treating injured vocal folds by implantation of bone marrow-derived stromal cells containing mesenchymal...
8.
Umeda H, Kanemaru S, Yamashita M, Ohno T, Suehiro A, Tamura Y, et al.
Acta Otolaryngol . 2009 Nov; 129(12):1509-18. PMID: 19922106
Conclusion: Calcium alginate (CA) membrane prevents excessive fibrous tissue intrusion and/or dislocation of a bone scaffold. However, CA membrane did not always accelerate cranial bone regeneration. Objective: We previously reported...
9.
Kishimoto Y, Hirano S, Kitani Y, Suehiro A, Umeda H, Tateya I, et al.
Laryngoscope . 2009 Oct; 120(1):108-13. PMID: 19877197
Objectives/hypothesis: Therapeutic challenges exist in the management of vocal fold scarring. We have previously demonstrated the therapeutic potential of hepatocyte growth factor (HGF) in the management of acute phase vocal...
10.
Ohno T, Hirano S, Kanemaru S, Yamashita M, Umeda H, Suehiro A, et al.
Eur Arch Otorhinolaryngol . 2007 Nov; 265(6):669-74. PMID: 17989988
Vocal fold scarring remains a therapeutic challenge. Our research group has indicated that bone marrow-derived stromal cells (BSCs) may have therapeutic potential in restoration of injured vocal folds. However, it...